Navigation Links
Omeros Announces Publication of MASP-2 Data in Proceedings of the National Academy of Sciences
Date:4/19/2011

SEATTLE, April 19, 2011 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that research on mannan-binding lectin-associated serine protease-2 (MASP-2) has been published in the April 18, 2011 Early Online Edition of the Proceedings of the National Academy of Sciences (PNAS).  Wilhelm Schwaeble, Ph.D., Professor of Immunology at the University of Leicester and the senior author of the paper, led an international team of researchers who demonstrated that blocking MASP-2 function significantly reduces tissue damage caused by ischemia-reperfusion injury.

Ischemia is the interruption of blood flow to tissue, which can be caused by myocardial infarctions (heart attacks), strokes and other medical disorders as well as a wide range of surgical procedures.  When blood flow is restored to ischemic tissue (reperfusion), the process can trigger an excessive inflammatory response leading to tissue destruction and impaired organ function. MASP-2, which was first identified by researchers at the University of Leicester, is a pro-inflammatory protein target in the complement system. The complement system, an important component of the immune system, initiates an inflammatory response as a result of tissue damage or microbial pathogen invasion.  

Professor Schwaeble and his colleagues demonstrated in animal models of cardiac and gastrointestinal ischemia-reperfusion injury that inhibition of MASP-2 function blocked the excessive inflammatory response, resulting in significantly less tissue damage.

MASP-2 is a key component of the innate immune response and its inhibition could potentially provide a novel approach to treating other inflammatory disorders, including neuropathy and other complications of diabetes, age-related macular degeneration and autoimmune disorders.  Omeros holds worldwide exclusive intellectual-property rights related to
'/>"/>

SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Omeros Reports Outcome of Phase 3 Trials of OMS103HP
2. Omeros Corporation Reports Fourth Quarter and Year-End 2010 Financial Results
3. Omeros Unlocks Orphan GPCRs Linked to Pancreatic Cancer and Cognitive Disorders
4. Omeros Announces Expansion of Exclusive License to PDE7 Inhibitors from Daiichi Sankyo
5. Omeros Announces Publication of Data From Antifibrinolytic Program
6. Omeros Licenses Novel Antifibrinolytic Agents
7. Omeros Announces Positive Clinical Results of OMS201 in Patients Undergoing Ureteroscopy
8. Omeros to Host Conference Call Monday, October 25 at 4:00 p.m. ET To Provide Corporate Update
9. Omeros to Present at the BioCentury NewsMakers Conference
10. Omeros Enrolls First Patient in Phase 2b Clinical Trial Evaluating OMS302 in Patients Undergoing Cataract Surgery
11. Omeros Successfully Unlocks Orphan GPCRs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... CHAPEL HILL, N.C. , Dec. 23, 2014 /PRNewswire/ ... marketplace success. As the key link between the medical ... will grow even more in the coming years as ... relationships. According to research by benchmarking ... and MSLs can gain an important edge is by ...
(Date:12/22/2014)... VIEJO, Calif. , Dec. 22, 2014 ... into expanded corporate offices in Aliso Viejo ... announced that due to the tremendous growth and worldwide ... needed. Sales of patented SnoreRx, the anti snore cure ... offices. He said, "We are now in 23 ...
(Date:12/22/2014)... 2014 Research and Markets ( ... "Investment Analysis of the US Medical Device ... http://photos.prnewswire.com/prnh/20130307/600769 ... device sector identifies the key trends and rationale ... and mergers and acquisitions. The study ...
Breaking Medicine Technology:Role of Medical Science Liaisons Evolving in Medical Device Sector 2Investment Analysis of the US Medical Device Sector 2
(Date:12/25/2014)... 26, 2014 The report “TS-1 (Colorectal ... on the current treatment landscape, unmet needs, current pipeline ... is an anti-cancer drug which is typically used for ... also used for treating gastric cancer and pancreatic cancer. ... The drug was first approved in 1999 in Japan ...
(Date:12/25/2014)... The short film “Color of Honor” by young ... a true 9/11 hero, Welles Remy Crowther. It has been ... hours of Nuremberg International Short Film Festival and the 8th ... screenwriter and director Luciana Lagana plays the mother of ... husband, Gregory Graham - Graham plays a heroic ...
(Date:12/25/2014)... Recently, LunaDress.co.uk has updated its blog to provide professional shopping ... of the models at LunaDress.co.uk come with big discounts, up to ... veil can turn out to be a most exciting memory and ... always bring surprise to a wedding. On the updated fashion blog, ... veils for a big day . , Going out with friends ...
(Date:12/25/2014)... Dennis Thompson HealthDay Reporter ... closing in on a "fountain of youth" drug that can ... older adults, a new study suggests. Seniors received a ... that targets a genetic signaling pathway linked to aging and ... The experimental medication, a version of the drug ...
(Date:12/25/2014)... December 25, 2014 Residents at ... Community, recently showed their generous spirit by providing ... Catawba County Parenting Network- Grandparents Raising Grandchildren program. ... gathered around the largest Christmas tree on the ... purchased by residents of the Abernethy Village Association ...
Breaking Medicine News(10 mins):Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Retirement Community Residents Make Impact During Holiday Season 2
... than doubled since the collapse of the Soviet Union, according ... women smoked, compared to almost 15 per cent by 2003. ... has risen from 57 per cent to 63 per cent. ... Tobacco Control, blame the privatisation of the previously state owned ...
... Research Institute (CRI) announced today that it has brought ... Sabin Vaccine Institute, and the Cancer Vaccine Collaborative, a ... Ludwig Institute for Cancer Research (LICR), to form the ... a unified voice in the cancer vaccine field and ...
... annual,Guaranteed Living Benefits (GLB) survey of leading U.S. variable ... offered,include some form of GLB., Total sales of ... 87% of total VA sales, stable relative to 2004 ... up to 95% during the first,half of 2007, demonstrating ...
... MEDai, Inc., headquartered in,Orlando, FL, a ... its longstanding Pinpoint Quality(TM) client, Sharp,HealthCare of ... Malcolm Baldrige National,Quality Award., The Baldrige ... for quality and organizational performance excellence. Congress,established ...
... Walsh appears in PSAs for personal health record ... American Health Information,Management Association (AHIMA) launched the "It,s ... healthcare consumers on the,importance of improving the management ... (PHR)., This campaign encourages Americans -- especially ...
... In a reversal of what has,become the norm, Link ... coupled with two hours of live phone,tech support and ... EZM Web tracks and controls maintenance for any ... control via the Web. It is accessible,from anywhere in ...
Cached Medicine News:Health News:Number of Russian women smokers has doubled since Soviet collapse 2Health News:Cancer Vaccine Consortium and Cancer Vaccine Collaborative unite under the Cancer Research Institute 2Health News:Cancer Vaccine Consortium and Cancer Vaccine Collaborative unite under the Cancer Research Institute 3Health News:Milliman Survey Confirms Continued Dominance of Guarantees in Variable Annuity Retirement Income Products 2Health News:Milliman Survey Confirms Continued Dominance of Guarantees in Variable Annuity Retirement Income Products 3Health News:MEDai Client Named Recipient of 2007 Malcolm Baldrige National Quality Award 2Health News:MEDai Client Named Recipient of 2007 Malcolm Baldrige National Quality Award 3Health News:AHIMA Launches National PHR Consumer Awareness Campaign 2Health News:Maintenance Software Company Bucks Trend, Offers Unlimited No-Charge Product Tech Support 2
... device the two steps are performed in ... Proteus' single use disposable cartridge and placed ... operator touches a button, and the cycle ... centrifugation. Then the integral syringe pump concentrates ...
Avitene Microfibrillar Collagen (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical....
Avitene Microfibrillar Collagen Hemostat (MCH) is used in surgical procedures as an to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical....
... based upon the physiological form and ... segment unit. Kinematics and morphology of ... and anatomical aspects of the physiological ... components utilizing proven implant materials: Forged ...
Medicine Products: